Drug information for KADIAN

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE, EXTENDED RELEASE; ORAL 100MG Prescription AB (Reference Drug) MORPHINE SULFATE Morphine ACTAVIS ELIZABETH 20616
2011-02-04 Review
2007-11-19 Review
2007-11-19 Review
2007-05-01 Letter
2007-04-25 Label
2007-03-07 Letter
2007-03-07 Letter
2007-03-07 Label
2007-03-07 Label
2006-11-06 Label
2006-11-06 Letter
2005-10-20 Letter
2005-09-30 Label
CAPSULE, EXTENDED RELEASE; ORAL 10MG Prescription  (Reference Drug) MORPHINE SULFATE Morphine ACTAVIS ELIZABETH   "
CAPSULE, EXTENDED RELEASE; ORAL 200MG Prescription  (Reference Drug) MORPHINE SULFATE Morphine ACTAVIS ELIZABETH   "
CAPSULE, EXTENDED RELEASE; ORAL 20MG Prescription AB  MORPHINE SULFATE Morphine ACTAVIS ELIZABETH   "
CAPSULE, EXTENDED RELEASE; ORAL 30MG Prescription AB  MORPHINE SULFATE Morphine ACTAVIS ELIZABETH   "
CAPSULE, EXTENDED RELEASE; ORAL 50MG Prescription AB  MORPHINE SULFATE Morphine ACTAVIS ELIZABETH   "
CAPSULE, EXTENDED RELEASE; ORAL 60MG Prescription AB  MORPHINE SULFATE Morphine ACTAVIS ELIZABETH   "
CAPSULE, EXTENDED RELEASE; ORAL 80MG Prescription AB  MORPHINE SULFATE Morphine ACTAVIS ELIZABETH   "

Drug Adverse Effects information for KADIAN

Role code Indications Reaction # Reports
SS BLOOD CHOLESTEROL INCREASED DIZZINESS 1
SS BLOOD CHOLESTEROL INCREASED NIGHT BLINDNESS 1
SS BLOOD CHOLESTEROL INCREASED VISION BLURRED 1
SS BLOOD CHOLESTEROL INCREASED VISUAL ACUITY REDUCED 1
SS FIBROMYALGIA DIZZINESS 1
SS FIBROMYALGIA NIGHT BLINDNESS 1
SS FIBROMYALGIA VISION BLURRED 1
SS FIBROMYALGIA VISUAL ACUITY REDUCED 1
SS HYPERTENSION DIZZINESS 1
SS HYPERTENSION NIGHT BLINDNESS 1
SS HYPERTENSION VISION BLURRED 1
SS HYPERTENSION VISUAL ACUITY REDUCED 1
SS INTERVERTEBRAL DISC DEGENERATION DIZZINESS 1
SS INTERVERTEBRAL DISC DEGENERATION NIGHT BLINDNESS 1
SS INTERVERTEBRAL DISC DEGENERATION VISION BLURRED 1
SS INTERVERTEBRAL DISC DEGENERATION VISUAL ACUITY REDUCED 1
SS OSTEOPOROSIS DIZZINESS 4
SS OSTEOPOROSIS NIGHT BLINDNESS 4
SS OSTEOPOROSIS VISION BLURRED 4
SS OSTEOPOROSIS VISUAL ACUITY REDUCED 4
SS PAIN DIZZINESS 1
SS PAIN HYPERTENSIVE HEART DISEASE 2
SS PAIN NIGHT BLINDNESS 1
SS PAIN TOXICITY TO VARIOUS AGENTS 2
SS PAIN VISION BLURRED 1
SS PAIN VISUAL ACUITY REDUCED 1
SS PRODUCT USED FOR UNKNOWN INDICATION FACE OEDEMA 10
SS SLEEP DISORDER DIZZINESS 1
SS SLEEP DISORDER NIGHT BLINDNESS 1
SS SLEEP DISORDER VISION BLURRED 1
SS SLEEP DISORDER VISUAL ACUITY REDUCED 1
SS THYROID DISORDER DIZZINESS 1
SS THYROID DISORDER NIGHT BLINDNESS 1
SS THYROID DISORDER VISION BLURRED 1
SS THYROID DISORDER VISUAL ACUITY REDUCED 1
C BACK PAIN ABDOMINAL PAIN UPPER 1
C BLADDER DISORDER ARTHRALGIA 2
C BLADDER DISORDER NAUSEA 2
C BLADDER DISORDER VISUAL FIELD DEFECT 2
C BLOOD CHOLESTEROL DYSPEPSIA 1
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE ABDOMINAL PAIN UPPER 1
C LUNG INFECTION RASH 1
C MULTIPLE MYELOMA DECREASED APPETITE 2
C MULTIPLE MYELOMA ENTEROCOLITIS 2
C MULTIPLE MYELOMA ENTEROCOLITIS INFECTIOUS 2
C MULTIPLE MYELOMA INFECTION 2
C MULTIPLE MYELOMA NEUTROPENIA 2
C MULTIPLE MYELOMA PLATELET COUNT DECREASED 2
C MULTIPLE MYELOMA WHITE BLOOD CELL COUNT INCREASED 2
C MULTIPLE SCLEROSIS ARTHRALGIA 3
C MULTIPLE SCLEROSIS NAUSEA 3
C MULTIPLE SCLEROSIS VISUAL FIELD DEFECT 3
C PAIN ARTHRALGIA 1
C PAIN NAUSEA 1
C PAIN VISUAL FIELD DEFECT 1
C PANCREATIC CARCINOMA DEATH 1
C PANCREATIC CARCINOMA INCORRECT DOSE ADMINISTERED 1
C PRODUCT USED FOR UNKNOWN INDICATION DEATH 10
C PRODUCT USED FOR UNKNOWN INDICATION INCORRECT DOSE ADMINISTERED 10
C PROPHYLAXIS DECREASED APPETITE 7
C PROPHYLAXIS ENTEROCOLITIS 7
C PROPHYLAXIS ENTEROCOLITIS INFECTIOUS 7
C PROPHYLAXIS INFECTION 7
C PROPHYLAXIS NEUTROPENIA 7
C PROPHYLAXIS PLATELET COUNT DECREASED 7
C PROPHYLAXIS WHITE BLOOD CELL COUNT INCREASED 7
Ads by Google